A total of 37 formalin-fixed, paraffin-embedded tissues were obtained from patients diagnosed with SCLC by bronchofiberscopy or biopsy between January 2012 and March 2015. All patients received care and follow-up in our hospital. Informed consent was obtained under the protocol approved by our hospital's ethics committee. The clinical characteristics are summarized in Table 1.
The endogenous peroxidase activity was blocked by soaking the deparaffinized specimens in 3.3% H2O2. The specimens were then incubated with primary antibodies (MST2, 1 : 200, ab87322, abcam; pMST2 (phosphor Thr180), 1 : 200, PA5-104616, Invitrogen; YAP1, 1 : 100, ab205270, abcam; pYAP1 (phosphor S127), 1 : 100,ab76252, abcam; CD133, 1 : 100, ab216323, Abcam) and the corresponding secondary antibodies [20 (link)]. Semiquantitative results were obtained by using the German semiquantitative scoring method, as previously described [21 (link)].
Free full text: Click here